Identification of Drosophila heart-specific Cis-Regulatory Modules under Hox control

Cardiac morphogenesis is a complex process governed by evolutionarily conserved transcription factors and signaling molecules. The Drosophila cardiac tube is linear, made of 52 pairs of cardiomyocytes (CMs), which express specific transcription factor genes that have human homologues implicated in Congenital Heart Diseases (CHDs) (NKX2-5, GATA4 and TBX5). The Drosophila cardiac tube is linear and composed of a rostral portion named aorta and a caudal one called heart, distinguished by morphological and functional differences controlled by Hox genes, key regulators of axial patterning. Overexpression and inactivation of the Hox gene abdominal-A (abd-A), which is expressed exclusively in the heart, revealed that abd-A controls heart identity. The aim of our work is to isolate the heart-specific cisregulatory sequences of abd-A direct target genes, the realizator genes granting heart identity. In each segment of the heart, four pairs of cardiomyocytes (CMs) express tinman (tin), homologous to NKX2-5, and acquire strong contractile and automatic rhythmic activities. By tyramide amplified FISH, we found that seven genes, encoding ion channels, pumps or transporters, are specifically expressed in the Tin-CMs of the heart. We initially used online available tools to identify their heart-specific cisregutatory modules by looking for Conserved Non-coding Sequences containing clusters of binding sites for various cardiac transcription factors, including Hox proteins. Based on these data we generated several reporter gene constructs and transgenic embryos, but none of them showed reporter gene expression in the heart. In order to identify additional abd-A target genes, we performed microarray experiments comparing the transcriptomes of aorta versus heart and identified 144 genes overexpressed in the heart. In order to find the heart-specific cis-regulatory regions of these target genes we developed a new bioinformatic approach where prediction is based on pattern matching and ordered statistics. We first retrieved Conserved Noncoding Sequences from the alignment between the D.melanogaster and D.pseudobscura genomes. We scored for combinations of conserved occurrences of ABD-A, ABD-B, TIN, PNR, dMEF2, MADS box, T-box and E-box sites and we ranked these results based on two independent strategies. On one hand we ranked the putative cis-regulatory sequences according to best scored ABD-A biding sites, on the other hand we scored according to conservation of binding sites. We integrated and ranked again the two lists obtained independently to produce a final rank. We generated nGFP reporter construct flies for in vivo validation. We identified three 1kblong heart-specific enhancers. By in vivo and in vitro experiments we are determining whether they are direct abd-A targets, demonstrating the role of a Hox gene in the realization of heart identity. The identified abd-A direct target genes may be targets also of the NKX2-5, GATA4 and/or TBX5 homologues tin, pannier and Doc genes, respectively. The identification of sequences coregulated by a Hox protein and the homologues of transcription factors causing CHDs, will provide a mean to test whether these factors function as Hox cofactors granting cardiac specificity to Hox proteins, increasing our knowledge on the molecular mechanisms underlying CHDs. Finally, it may be investigated whether these Hox targets are involved in CHDs.

Computational analyses on the structure-function relation in ion channels

Ion channels are protein molecules, embedded in the lipid bilayer of the cell membranes. They act as powerful sensing elements switching chemicalphysical stimuli into ion-fluxes. At a glance, ion channels are water-filled pores, which can open and close in response to different stimuli (gating), and one once open select the permeating ion species (selectivity). They play a crucial role in several physiological functions, like nerve transmission, muscular contraction, and secretion. Besides, ion channels can be used in technological applications for different purpose (sensing of organic molecules, DNA sequencing). As a result, there is remarkable interest in understanding the molecular determinants of the channel functioning. Nowadays, both the functional and the structural characteristics of ion channels can be experimentally solved. The purpose of this thesis was to investigate the structure-function relation in ion channels, by computational techniques. Most of the analyses focused on the mechanisms of ion conduction, and the numerical methodologies to compute the channel conductance. The standard techniques for atomistic simulation of complex molecular systems (Molecular Dynamics) cannot be routinely used to calculate ion fluxes in membrane channels, because of the high computational resources needed. The main step forward of the PhD research activity was the development of a computational algorithm for the calculation of ion fluxes in protein channels. The algorithm - based on the electrodiffusion theory - is computational inexpensive, and was used for an extensive analysis on the molecular determinants of the channel conductance. The first record of ion-fluxes through a single protein channel dates back to 1976, and since then measuring the single channel conductance has become a standard experimental procedure. Chapter 1 introduces ion channels, and the experimental techniques used to measure the channel currents. The abundance of functional data (channel currents) does not match with an equal abundance of structural data. The bacterial potassium channel KcsA was the first selective ion channels to be experimentally solved (1998), and after KcsA the structures of four different potassium channels were revealed. These experimental data inspired a new era in ion channel modeling. Once the atomic structures of channels are known, it is possible to define mathematical models based on physical descriptions of the molecular systems. These physically based models can provide an atomic description of ion channel functioning, and predict the effect of structural changes. Chapter 2 introduces the computation methods used throughout the thesis to model ion channels functioning at the atomic level. In Chapter 3 and Chapter 4 the ion conduction through potassium channels is analyzed, by an approach based on the Poisson-Nernst-Planck electrodiffusion theory. In the electrodiffusion theory ion conduction is modeled by the drift-diffusion equations, thus describing the ion distributions by continuum functions. The numerical solver of the Poisson- Nernst-Planck equations was tested in the KcsA potassium channel (Chapter 3), and then used to analyze how the atomic structure of the intracellular vestibule of potassium channels affects the conductance (Chapter 4). As a major result, a correlation between the channel conductance and the potassium concentration in the intracellular vestibule emerged. The atomic structure of the channel modulates the potassium concentration in the vestibule, thus its conductance. This mechanism explains the phenotype of the BK potassium channels, a sub-family of potassium channels with high single channel conductance. The functional role of the intracellular vestibule is also the subject of Chapter 5, where the affinity of the potassium channels hEag1 (involved in tumour-cell proliferation) and hErg (important in the cardiac cycle) for several pharmaceutical drugs was compared. Both experimental measurements and molecular modeling were used in order to identify differences in the blocking mechanism of the two channels, which could be exploited in the synthesis of selective blockers. The experimental data pointed out the different role of residue mutations in the blockage of hEag1 and hErg, and the molecular modeling provided a possible explanation based on different binding sites in the intracellular vestibule. Modeling ion channels at the molecular levels relates the functioning of a channel to its atomic structure (Chapters 3-5), and can also be useful to predict the structure of ion channels (Chapter 6-7). In Chapter 6 the structure of the KcsA potassium channel depleted from potassium ions is analyzed by molecular dynamics simulations. Recently, a surprisingly high osmotic permeability of the KcsA channel was experimentally measured. All the available crystallographic structure of KcsA refers to a channel occupied by potassium ions. To conduct water molecules potassium ions must be expelled from KcsA. The structure of the potassium-depleted KcsA channel and the mechanism of water permeation are still unknown, and have been investigated by numerical simulations. Molecular dynamics of KcsA identified a possible atomic structure of the potassium-depleted KcsA channel, and a mechanism for water permeation. The depletion from potassium ions is an extreme situation for potassium channels, unlikely in physiological conditions. However, the simulation of such an extreme condition could help to identify the structural conformations, so the functional states, accessible to potassium ion channels. The last chapter of the thesis deals with the atomic structure of the !- Hemolysin channel. !-Hemolysin is the major determinant of the Staphylococcus Aureus toxicity, and is also the prototype channel for a possible usage in technological applications. The atomic structure of !- Hemolysin was revealed by X-Ray crystallography, but several experimental evidences suggest the presence of an alternative atomic structure. This alternative structure was predicted, combining experimental measurements of single channel currents and numerical simulations. This thesis is organized in two parts, in the first part an overview on ion channels and on the numerical methods adopted throughout the thesis is provided, while the second part describes the research projects tackled in the course of the PhD programme. The aim of the research activity was to relate the functional characteristics of ion channels to their atomic structure. In presenting the different research projects, the role of numerical simulations to analyze the structure-function relation in ion channels is highlighted.

Transcriptional regulation of human mu-opioid receptor gene: functional characterization of activating and inhibitory transcription factors

The organization of the nervous and immune systems is characterized by obvious differences and striking parallels. Both systems need to relay information across very short and very long distances. The nervous system communicates over both long and short ranges primarily by means of more or less hardwired intercellular connections, consisting of axons, dendrites, and synapses. Longrange communication in the immune system occurs mainly via the ordered and guided migration of immune cells and systemically acting soluble factors such as antibodies, cytokines, and chemokines. Its short-range communication either is mediated by locally acting soluble factors or transpires during direct cell–cell contact across specialized areas called “immunological synapses” (Kirschensteiner et al., 2003). These parallels in intercellular communication are complemented by a complex array of factors that induce cell growth and differentiation: these factors in the immune system are called cytokines; in the nervous system, they are called neurotrophic factors. Neither the cytokines nor the neurotrophic factors appear to be completely exclusive to either system (Neumann et al., 2002). In particular, mounting evidence indicates that some of the most potent members of the neurotrophin family, for example, nerve growth factor (NGF) and brainderived neurotrophic factor (BDNF), act on or are produced by immune cells (Kerschensteiner et al., 1999) There are, however, other neurotrophic factors, for example the insulin-like growth factor-1 (IGF-1), that can behave similarly (Kermer et al., 2000). These factors may allow the two systems to “cross-talk” and eventually may provide a molecular explanation for the reports that inflammation after central nervous system (CNS) injury has beneficial effects (Moalem et al., 1999). In order to shed some more light on such a cross-talk, therefore, transcription factors modulating mu-opioid receptor (MOPr) expression in neurons and immune cells are here investigated. More precisely, I focused my attention on IGF-I modulation of MOPr in neurons and T-cell receptor induction of MOPr expression in T-lymphocytes. Three different opioid receptors [mu (MOPr), delta (DOPr), and kappa (KOPr)] belonging to the G-protein coupled receptor super-family have been cloned. They are activated by structurallyrelated exogenous opioids or endogenous opioid peptides, and contribute to the regulation of several functions including pain transmission, respiration, cardiac and gastrointestinal functions, and immune response (Zollner and Stein 2007). MOPr is expressed mainly in the central nervous system where it regulates morphine-induced analgesia, tolerance and dependence (Mayer and Hollt 2006). Recently, induction of MOPr expression in different immune cells induced by cytokines has been reported (Kraus et al., 2001; Kraus et al., 2003). The human mu-opioid receptor gene (OPRM1) promoter is of the TATA-less type and has clusters of potential binding sites for different transcription factors (Law et al. 2004). Several studies, primarily focused on the upstream region of the OPRM1 promoter, have investigated transcriptional regulation of MOPr expression. Presently, however, it is still not completely clear how positive and negative transcription regulators cooperatively coordinate cellor tissue-specific transcription of the OPRM1 gene, and how specific growth factors influence its expression. IGF-I and its receptors are widely distributed throughout the nervous system during development, and their involvement in neurogenesis has been extensively investigated (Arsenijevic et al. 1998; van Golen and Feldman 2000). As previously mentioned, such neurotrophic factors can be also produced and/or act on immune cells (Kerschenseteiner et al., 2003). Most of the physiologic effects of IGF-I are mediated by the type I IGF surface receptor which, after ligand binding-induced autophosphorylation, associates with specific adaptor proteins and activates different second messengers (Bondy and Cheng 2004). These include: phosphatidylinositol 3-kinase, mitogen-activated protein kinase (Vincent and Feldman 2002; Di Toro et al. 2005) and members of the Janus kinase (JAK)/STAT3 signalling pathway (Zong et al. 2000; Yadav et al. 2005). REST plays a complex role in neuronal cells by differentially repressing target gene expression (Lunyak et al. 2004; Coulson 2005; Ballas and Mandel 2005). REST expression decreases during neurogenesis, but has been detected in the adult rat brain (Palm et al. 1998) and is up-regulated in response to global ischemia (Calderone et al. 2003) and induction of epilepsy (Spencer et al. 2006). Thus, the REST concentration seems to influence its function and the expression of neuronal genes, and may have different effects in embryonic and differentiated neurons (Su et al. 2004; Sun et al. 2005). In a previous study, REST was elevated during the early stages of neural induction by IGF-I in neuroblastoma cells. REST may contribute to the down-regulation of genes not yet required by the differentiation program, but its expression decreases after five days of treatment to allow for the acquisition of neural phenotypes. Di Toro et al. proposed a model in which the extent of neurite outgrowth in differentiating neuroblastoma cells was affected by the disappearance of REST (Di Toro et al. 2005). The human mu-opioid receptor gene (OPRM1) promoter contains a DNA sequence binding the repressor element 1 silencing transcription factor (REST) that is implicated in transcriptional repression. Therefore, in the fist part of this thesis, I investigated whether insulin-like growth factor I (IGF-I), which affects various aspects of neuronal induction and maturation, regulates OPRM1 transcription in neuronal cells in the context of the potential influence of REST. A series of OPRM1-luciferase promoter/reporter constructs were transfected into two neuronal cell models, neuroblastoma-derived SH-SY5Y cells and PC12 cells. In the former, endogenous levels of human mu-opioid receptor (hMOPr) mRNA were evaluated by real-time PCR. IGF-I upregulated OPRM1 transcription in: PC12 cells lacking REST, in SH-SY5Y cells transfected with constructs deficient in the REST DNA binding element, or when REST was down-regulated in retinoic acid-differentiated cells. IGF-I activates the signal transducer and activator of transcription-3 (STAT3) signaling pathway and this transcription factor, binding to the STAT1/3 DNA element located in the promoter, increases OPRM1 transcription. T-cell receptor (TCR) recognizes peptide antigens displayed in the context of the major histocompatibility complex (MHC) and gives rise to a potent as well as branched intracellular signalling that convert naïve T-cells in mature effectors, thus significantly contributing to the genesis of a specific immune response. In the second part of my work I exposed wild type Jurkat CD4+ T-cells to a mixture of CD3 and CD28 antigens in order to fully activate TCR and study whether its signalling influence OPRM1 expression. Results were that TCR engagement determined a significant induction of OPRM1 expression through the activation of transcription factors AP-1, NF-kB and NFAT. Eventually, I investigated MOPr turnover once it has been expressed on T-cells outer membrane. It turned out that DAMGO induced MOPr internalisation and recycling, whereas morphine did not. Overall, from the data collected in this thesis we can conclude that that a reduction in REST is a critical switch enabling IGF-I to up-regulate human MOPr, helping these findings clarify how human MOPr expression is regulated in neuronal cells, and that TCR engagement up-regulates OPRM1 transcription in T-cells. My results that neurotrophic factors a and TCR engagement, as well as it is reported for cytokines, seem to up-regulate OPRM1 in both neurons and immune cells suggest an important role for MOPr as a molecular bridge between neurons and immune cells; therefore, MOPr could play a key role in the cross-talk between immune system and nervous system and in particular in the balance between pro-inflammatory and pro-nociceptive stimuli and analgesic and neuroprotective effects.

Caratterizzazione del legame di molecole di interesse farmaceutico alla sieroalbumina umana mediante biocromatografia e dicroismo circolare

Negli ultimi anni, un crescente numero di studiosi ha focalizzato la propria attenzione sullo sviluppo di strategie che permettessero di caratterizzare le proprietà ADMET dei farmaci in via di sviluppo, il più rapidamente possibile. Questa tendenza origina dalla consapevolezza che circa la metà dei farmaci in via di sviluppo non viene commercializzato perché ha carenze nelle caratteristiche ADME, e che almeno la metà delle molecole che riescono ad essere commercializzate, hanno comunque qualche problema tossicologico o ADME [1]. Infatti, poco importa quanto una molecola possa essere attiva o specifica: perché possa diventare farmaco è necessario che venga ben assorbita, distribuita nell’organismo, metabolizzata non troppo rapidamente, ne troppo lentamente e completamente eliminata. Inoltre la molecola e i suoi metaboliti non dovrebbero essere tossici per l’organismo. Quindi è chiaro come una rapida determinazione dei parametri ADMET in fasi precoci dello sviluppo del farmaco, consenta di risparmiare tempo e denaro, permettendo di selezionare da subito i composti più promettenti e di lasciar perdere quelli con caratteristiche negative. Questa tesi si colloca in questo contesto, e mostra l’applicazione di una tecnica semplice, la biocromatografia, per caratterizzare rapidamente il legame di librerie di composti alla sieroalbumina umana (HSA). Inoltre mostra l’utilizzo di un’altra tecnica indipendente, il dicroismo circolare, che permette di studiare gli stessi sistemi farmaco-proteina, in soluzione, dando informazioni supplementari riguardo alla stereochimica del processo di legame. La HSA è la proteina più abbondante presente nel sangue. Questa proteina funziona da carrier per un gran numero di molecole, sia endogene, come ad esempio bilirubina, tiroxina, ormoni steroidei, acidi grassi, che xenobiotici. Inoltre aumenta la solubilità di molecole lipofile poco solubili in ambiente acquoso, come ad esempio i tassani. Il legame alla HSA è generalmente stereoselettivo e ad avviene a livello di siti di legame ad alta affinità. Inoltre è ben noto che la competizione tra farmaci o tra un farmaco e metaboliti endogeni, possa variare in maniera significativa la loro frazione libera, modificandone l’attività e la tossicità. Per queste sue proprietà la HSA può influenzare sia le proprietà farmacocinetiche che farmacodinamiche dei farmaci. Non è inusuale che un intero progetto di sviluppo di un farmaco possa venire abbandonato a causa di un’affinità troppo elevata alla HSA, o a un tempo di emivita troppo corto, o a una scarsa distribuzione dovuta ad un debole legame alla HSA. Dal punto di vista farmacocinetico, quindi, la HSA è la proteina di trasporto del plasma più importante. Un gran numero di pubblicazioni dimostra l’affidabilità della tecnica biocromatografica nello studio dei fenomeni di bioriconoscimento tra proteine e piccole molecole [2-6]. Il mio lavoro si è focalizzato principalmente sull’uso della biocromatografia come metodo per valutare le caratteristiche di legame di alcune serie di composti di interesse farmaceutico alla HSA, e sul miglioramento di tale tecnica. Per ottenere una miglior comprensione dei meccanismi di legame delle molecole studiate, gli stessi sistemi farmaco-HSA sono stati studiati anche con il dicroismo circolare (CD). Inizialmente, la HSA è stata immobilizzata su una colonna di silice epossidica impaccata 50 x 4.6 mm di diametro interno, utilizzando una procedura precedentemente riportata in letteratura [7], con alcune piccole modifiche. In breve, l’immobilizzazione è stata effettuata ponendo a ricircolo, attraverso una colonna precedentemente impaccata, una soluzione di HSA in determinate condizioni di pH e forza ionica. La colonna è stata quindi caratterizzata per quanto riguarda la quantità di proteina correttamente immobilizzata, attraverso l’analisi frontale di L-triptofano [8]. Di seguito, sono stati iniettati in colonna alcune soluzioni raceme di molecole note legare la HSA in maniera enantioselettiva, per controllare che la procedura di immobilizzazione non avesse modificato le proprietà di legame della proteina. Dopo essere stata caratterizzata, la colonna è stata utilizzata per determinare la percentuale di legame di una piccola serie di inibitori della proteasi HIV (IPs), e per individuarne il sito(i) di legame. La percentuale di legame è stata calcolata attraverso il fattore di capacità (k) dei campioni. Questo parametro in fase acquosa è stato estrapolato linearmente dal grafico log k contro la percentuale (v/v) di 1-propanolo presente nella fase mobile. Solamente per due dei cinque composti analizzati è stato possibile misurare direttamente il valore di k in assenza di solvente organico. Tutti gli IPs analizzati hanno mostrato un’elevata percentuale di legame alla HSA: in particolare, il valore per ritonavir, lopinavir e saquinavir è risultato maggiore del 95%. Questi risultati sono in accordo con dati presenti in letteratura, ottenuti attraverso il biosensore ottico [9]. Inoltre, questi risultati sono coerenti con la significativa riduzione di attività inibitoria di questi composti osservata in presenza di HSA. Questa riduzione sembra essere maggiore per i composti che legano maggiormente la proteina [10]. Successivamente sono stati eseguiti degli studi di competizione tramite cromatografia zonale. Questo metodo prevede di utilizzare una soluzione a concentrazione nota di un competitore come fase mobile, mentre piccole quantità di analita vengono iniettate nella colonna funzionalizzata con HSA. I competitori sono stati selezionati in base al loro legame selettivo ad uno dei principali siti di legame sulla proteina. In particolare, sono stati utilizzati salicilato di sodio, ibuprofene e valproato di sodio come marker dei siti I, II e sito della bilirubina, rispettivamente. Questi studi hanno mostrato un legame indipendente dei PIs ai siti I e II, mentre è stata osservata una debole anticooperatività per il sito della bilirubina. Lo stesso sistema farmaco-proteina è stato infine investigato in soluzione attraverso l’uso del dicroismo circolare. In particolare, è stato monitorata la variazione del segnale CD indotto di un complesso equimolare [HSA]/[bilirubina], a seguito dell’aggiunta di aliquote di ritonavir, scelto come rappresentante della serie. I risultati confermano la lieve anticooperatività per il sito della bilirubina osservato precedentemente negli studi biocromatografici. Successivamente, lo stesso protocollo descritto precedentemente è stato applicato a una colonna di silice epossidica monolitica 50 x 4.6 mm, per valutare l’affidabilità del supporto monolitico per applicazioni biocromatografiche. Il supporto monolitico monolitico ha mostrato buone caratteristiche cromatografiche in termini di contropressione, efficienza e stabilità, oltre che affidabilità nella determinazione dei parametri di legame alla HSA. Questa colonna è stata utilizzata per la determinazione della percentuale di legame alla HSA di una serie di poliamminochinoni sviluppati nell’ambito di una ricerca sulla malattia di Alzheimer. Tutti i composti hanno mostrato una percentuale di legame superiore al 95%. Inoltre, è stata osservata una correlazione tra percentuale di legame è caratteristiche della catena laterale (lunghezza e numero di gruppi amminici). Successivamente sono stati effettuati studi di competizione dei composti in esame tramite il dicroismo circolare in cui è stato evidenziato un effetto anticooperativo dei poliamminochinoni ai siti I e II, mentre rispetto al sito della bilirubina il legame si è dimostrato indipendente. Le conoscenze acquisite con il supporto monolitico precedentemente descritto, sono state applicate a una colonna di silice epossidica più corta (10 x 4.6 mm). Il metodo di determinazione della percentuale di legame utilizzato negli studi precedenti si basa su dati ottenuti con più esperimenti, quindi è necessario molto tempo prima di ottenere il dato finale. L’uso di una colonna più corta permette di ridurre i tempi di ritenzione degli analiti, per cui la determinazione della percentuale di legame alla HSA diventa molto più rapida. Si passa quindi da una analisi a medio rendimento a una analisi di screening ad alto rendimento (highthroughput- screening, HTS). Inoltre, la riduzione dei tempi di analisi, permette di evitare l’uso di soventi organici nella fase mobile. Dopo aver caratterizzato la colonna da 10 mm con lo stesso metodo precedentemente descritto per le altre colonne, sono stati iniettati una serie di standard variando il flusso della fase mobile, per valutare la possibilità di utilizzare flussi elevati. La colonna è stata quindi impiegata per stimare la percentuale di legame di una serie di molecole con differenti caratteristiche chimiche. Successivamente è stata valutata la possibilità di utilizzare una colonna così corta, anche per studi di competizione, ed è stata indagato il legame di una serie di composti al sito I. Infine è stata effettuata una valutazione della stabilità della colonna in seguito ad un uso estensivo. L’uso di supporti cromatografici funzionalizzati con albumine di diversa origine (ratto, cane, guinea pig, hamster, topo, coniglio), può essere proposto come applicazione futura di queste colonne HTS. Infatti, la possibilità di ottenere informazioni del legame dei farmaci in via di sviluppo alle diverse albumine, permetterebbe un migliore paragone tra i dati ottenuti tramite esperimenti in vitro e i dati ottenuti con esperimenti sull’animale, facilitando la successiva estrapolazione all’uomo, con la velocità di un metodo HTS. Inoltre, verrebbe ridotto anche il numero di animali utilizzati nelle sperimentazioni. Alcuni lavori presenti in letteratura dimostrano l’affidabilita di colonne funzionalizzate con albumine di diversa origine [11-13]: l’utilizzo di colonne più corte potrebbe aumentarne le applicazioni.

Interazioni tra Glicoproteine che mediano la penetrazione del Virus Herpes Simplex nella cellula e disegno razionale di Peptidi Inibitori

Herpes simplex virus entry into cells requires a multipartite fusion apparatus made of gD, gB and heterodimer gH/gL. gD serves as receptor-binding glycoprotein and trigger of fusion; its ectodomain is organized in a N-terminal domain carrying the receptor-binding sites, and a C-terminal domain carrying the profusion domain, required for fusion but not receptor-binding. gB and gH/gL execute fusion. To understand how the four glycoproteins cross-talk to each other we searched for biochemical defined complexes in infected and transfected cells, and in virions. We report that gD formed complexes with gB in absence of gH/gL, and with gH/gL in absence of gB. Complexes with similar composition were formed in infected and transfected cells. They were also present in virions prior to entry, and did not increase at virus fusion with cell. A panel of gD mutants enabled the preliminary location of part of the binding site in gD to gB to the aa 240-260 portion and downstream, with T306P307 as critical residues, and of the binding site to gH/gL at aa 260-310 portion, with P291P292 as critical residues. The results indicate that gD carries composite independent binding sites for gB and gH/gL, both of which partly located in the profusion domain. The second part of the project dealt with rational design of peptides inhibiting virus entry has been performed. Considering gB and gD, the crystal structure is known, so we designed peptides that dock in the structure or prevent the adoption of the final conformation of target molecule. Considering the other glycoproteins, of which the structure is not known, peptide libraries were analyzed. Among several peptides, some were identified as active, designed on glycoprotein B. Two of them were further analyzed. We identified peptide residues fundamental for the inhibiting activity, suggesting a possible mechanism of action. Furthermore, changing the flexibility of peptides, an increased activity was observed,with an EC50 under 10μM. New approaches will try to demonstrate the direct interaction between these peptides and the target glycoprotein B.

Intrinsic uncoupling in the ATP synthase of Escherichia coli. Studies on WT and ε-truncated mutants

The H+/ATP ratio in the catalysis of ATP synthase has generally been considered a fixed parameter. However, Melandri and coworkers have recently shown that, in the ATP synthase of the photosynthetic bacterium Rb.capsulatus, this ratio can significantly decrease during ATP hydrolysis when the concentration of either ADP or Pi is maintained at a low level (Turina et al., 2004). The present work has dealt with the ATP synthase of E.coli, looking for evidence of this phenomenon of intrinsic uncoupling in this organism as well. First of all, we have shown that the DCCD-sensitive ATP hydrolysis activity of E.coli internal membranes was strongly inhibited by ADP and Pi, with a half-maximal effect in the submicromolar range for ADP and at 140 µM for Pi. In contrast to this monotonic inhibition, however, the proton pumping activity of the enzyme, as estimated under the same conditions by the fluorescence quenching of the ΔpH-sensitive probe ACMA, showed a clearly biphasic progression, both for Pi, increasing from 0 up to approximately 200 µM, and for ADP, increasing from 0 up to a few µM. We have interpreted these results as indicating that the occupancy of ADP and Pi binding sites shifts the enzyme from a partially uncoupled state to a fully coupled state, and we expect that the ADP- and Pi-modulated intrinsic uncoupling is likely to be a general feature of prokaryotic ATP synthases. Moreover, the biphasicity of the proton pumping data suggested that two Pi binding sites are involved. In order to verify whether the same behaviour could be observed in the isolated enzyme, we have purified the ATP synthase of E.coli and reconstituted it into liposomes. Similarly as observed in the internal membrane preparation, in the isolated and reconstituted enzyme it was possible to observe inhibition of the hydrolytic activity by ADP and Pi (with half-maximal effects at few µM for ADP and at 400 µM for Pi) with a concomitant stimulation of proton pumping. Both the inhibition of ATP hydrolysis and the stimulation of proton pumping as a function of Pi were lost upon ADP removal by an ADP trap. These data have made it possible to conclude that the results obtained in E.coli internal membranes are not due to the artefactual interference of enzymatic activities other than the ones of the ATP synthase. In addition, data obtained with liposomes have allowed a calibration of the ACMA signal by ΔpH transitions of known extent, leading to a quantitative evaluation of the proton pumping data. Finally, we have focused our efforts on searching for a possible structural candidate involved in the phenomenon of intrinsic uncoupling. The ε-subunit of the ATP-synthase is known as an endogenous inhibitor of the hydrolysis activity of the complex and appears to undergo drastic conformational changes between a non-inhibitory form (down-state) and an inhibitory form (up-state)(Rodgers & Wilce, 2000; Gibbons et al., 2000). In addition, the results of Cipriano & Dunn (2006) indicated that the C-terminal domain of this subunit played an important role in the coupling mechanism of the pump, and those of Capaldi et al. (2001), Suzuki et al. (2003) were consistent with the down-state showing a higher hydrolysis-to-synthesis ratio than the up-state. Therefore, we decided to search for modulation of pumping efficiency in a C-terminally truncated ε mutant. A low copy number expression vector has been built, carrying an extra copy of uncC, with the aim of generating an ε-overexpressing E.coli strain in which normal levels of assembly of the mutated ATP-synthase complex would be promoted. We have then compared the ATP hydrolysis and the proton pumping activity in membranes prepared from these ε-overexpressing E.coli strains, which carried either the WT ε subunit or the ε88-stop truncated form. Both strains yielded well energized membranes. Noticeably, they showed a marked difference in the inhibition of hydrolysis by Pi, this effect being largely lost in the truncated mutant. However, pre-incubation of the mutated enzyme with ADP at low nanomolar concentrations (apparent Kd = 0.7nM) restored the hydrolysis inhibition, together with the modulation of intrinsic uncoupling by Pi, indicating that, contrary to wild-type, during membrane preparation the truncated mutant had lost the ADP bound at this high-affinity site, evidently due to a lower affinity (and/or higher release) for ADP of the mutant relative to wild type. Therefore, one of the effects of the C-terminal domain of ε appears to be to modulate the affinity of at least one of the binding sites for ADP. The lack of this domain does not appear so much to influence the modulability of coupling efficiency, but instead the extent of this modulation. At higher preincubated ADP concentrations (apparent Kd = 117nM), the only observed effects were inhibition of both hydrolysis and synthesis, providing a direct proof that two ADP-binding sites on the enzyme are involved in the inhibition of hydrolysis, of which only the one at higher affinity also modulates the coupling efficiency.

Cross-Talk tra Bifidobacterium e intestino umano: impatto sulle attività health promoting

Bifidobacteria constitute up to 3% of the total microbiota and represent one of the most important healthpromoting bacterial groups of the human intestinal microflora. The presence of Bifidobacterium in the human gastrointestinal tract has been directly related to several health-promoting activities; however, to date, no information about the specific mechanisms of interaction with the host is available. The first health-promoting activities studied in these job was the oxalate-degrading activity. Oxalic acid occurs extensively in nature and plays diverse roles, especially in pathological processes. Due to its highly oxidizing effects, hyper absorption or abnormal synthesis of oxalate can cause serious acute disorders in mammals and be lethal in extreme cases. Intestinal oxalate-degrading bacteria could therefore be pivotal in maintaining oxalate homeostasis, reducing the risk of kidney stone development. In this study, the oxalate-degrading activity of 14 bifidobacterial strains was measured by a capillary electrophoresis technique. The oxc gene, encoding oxalyl-CoA decarboxylase, a key enzyme in oxalate catabolism, was isolated by probing a genomic library of B. animalis subsp. lactis BI07, which was one of the most active strains in the preliminary screening. The genetic and transcriptional organization of oxc flanking regions was determined, unravelling the presence of other two independently transcribed open reading frames, potentially responsible for B. animalis subsp. lactis ability to degrade oxalate. Transcriptional analysis, using real-time quantitative reverse transcription PCR, revealed that these genes were highly induced in cells first adapted to subinhibitory concentrations of oxalate and then exposed to pH 4.5. Acidic conditions were also a prerequisite for a significant oxalate degradation rate, which dramatically increased in oxalate pre-adapted cells, as demonstrated in fermentation experiments with different pH-controlled batch cultures. These findings provide new insights in the characterization of oxalate-degrading probiotic bacteria and may support the use of B. animalis subsp. lactis as a promising adjunct for the prophylaxis and management of oxalate-related kidney disease. In order to provide some insight into the molecular mechanisms involved in the interaction with the host, in the second part of the job, we investigated whether Bifidobacterium was able to capture human plasminogen on the cell surface. The binding of human plasminogen to Bifidobacterium was dependent on lysine residues of surface protein receptors. By using a proteomic approach, we identified six putative plasminogen-binding proteins in the cell wall fraction of three strain of Bifidobacterium. The data suggest that plasminogen binding to Bifidobactrium is due to the concerted action of a number of proteins located on the bacterial cell surface, some of which are highly conserved cytoplasmic proteins which have other essential cellular functions. Our findings represent a step forward in understanding the mechanisms involved in the Bifidobacterium-host interaction. In these job w studied a new approach based on to MALDI-TOF MS to measure the interaction between entire bacterial cells and host molecular target. MALDI-TOF (Matrix Assisted Laser Desorption Ionization-Time of Flight)—mass spectrometry has been applied, for the first time, in the investigation of whole Bifidobacterium cells-host target proteins interaction. In particular, by means of this technique, a dose dependent human plasminogen-binding activity has been shown for Bifidobacterium. The involvement of lysine binding sites on the bacterial cell surface has been proved. The obtained result was found to be consistent with that from well-established standard methodologies, thus the proposed MALDI-TOF approach has the potential to enter as a fast alternative method in the field of biorecognition studies involving in bacterial cells and proteins of human origin.

Composti organostannici nell'ambiente marino e membrane biologiche: risposte molecolari e biochimiche nei molluschi bivalvi

Organotin compounds are worldwide diffused environmental contaminants, mainly as consequence of their extensive past use as biocides in antifouling paints. In spite of law restrictions, due to unwanted effects, organotin still persist in waters, being poorly degraded, easily resuspended from sediments and bioaccumulated in exposed organisms. The widespread toxicity and the possible threat to humans, likely to be organotin-exposed through contaminated seafood, make organotin interactions with biomolecules an intriguing biochemical topic, apart from a matter of ecotoxicological concern. Among organotins, tributyltin (TBT) is long known as the most dangerous and abundant chemical species in the Mediterranean Sea. Due to its amphiphilic nature, provided by three lipophilic arms and an electrophilic tin core, TBT can be easily incorporated in biomembranes and affect their functionality. Accordingly, it is known as a membrane-active toxicant and a mitochondrial poison. Up to now the molecular action modes of TBT are still partially unclear and poorly explored in bivalve mollusks, even if the latter play a not neglectable role in the marine trophic chain and efficiently accumulate organotins. The bivalve mollusk Mytilus galloprovincialis, selected for all experiments, is widely cultivated in the Mediterranean and currently used in ecotoxicological studies. Most work of this thesis was devoted to TBT effects on mussel mitochondria, but other possible targets of TBT were also considered. A great deal of literature points out TBT as endocrine disrupter and the masculinization of female marine gastropods, the so-called imposex, currently signals environmental organotin contamination. The hormonal status of TBT-exposed mussels and the possible interaction between hormones and contaminants in modulating microsomal hydroxilases, involved in steroid hormone and organotin detoxification, were the research topics in the period spent in Barcelona (Marco Polo fellowship). The variegated experimental approach, which consisted of two exposure experiments and in vitro tests, and the choice of selected tissues of M. galloprovincialis, the midgut gland for mitochondrial and microsomal preparations for subsequent laboratory assays and the gonads for the endocrine evaluations, aimed at drawing a clarifying pattern on the molecular mechanisms involved in organotin toxicity. TBT was promptly incorporated in midgut gland mitochondria of adult mussels exposed to 0.5 and 1.0 μg/L TBT, and partially degraded to DBT. TBT incorporation was accompanied by a decrease in the mitochondrial oligomycin-sensitive Mg-ATPase activity, while the coexistent oligomycin-insensitive fraction was unaffected. Mitochondrial fatty acids showed a clear rise in n-3 polyunsaturated fatty acids after 120 hr of TBT exposure, mainly referable to an increase in 22:6 level. TBT was also shown to inhibit the ATP hydrolytic activity of the mitochondrial F1FO complex in vitro and to promote an apparent loss of oligomycin sensitivity at higher than 1.0 μM concentration. The complex dose-dependent profile of the inhibition curve lead to the hypothesis of multiple TBT binding sites. At lower than 1.0 μM TBT concentrations the non competitive enzyme inhibition by TBT was ascribed to the non covalent binding of TBT to FO subunit. On the other hand the observed drop in oligomycin sensitivity at higher than 1.0 μM TBT could be related to the onset of covalent bonds involving thiolic groups on the enzyme structure, apparently reached only at high TBT levels. The mitochondrial respiratory complexes were in vitro affected by TBT, apart from the cytocrome c oxidase which was apparently refractory to the contaminant. The most striking inhibitory effect was shown on complex I, and ascribed to possible covalent bonds of TBT with –SH groups on the enzyme complexes. This mechanism, shouldered by the progressive decrease of free cystein residues in the presence of increasing TBT concentrations, suggests that the onset of covalent tin-sulphur bonds in distinct protein structures may constitute the molecular basis of widespread TBT effects on mitochondrial complexes. Energy production disturbances, in turn affecting energy consuming mechanisms, could be involved in other cellular changes. Mussels exposed to a wide range of TBT concentrations (20 - 200 and 2000 ng/L respectively) did not show any change in testosterone and estrogen levels in mature gonads. Most hormones were in the non-biologically active esterified form both in control and in TBT-treated mussels. Probably the endocrine status of sexually mature mussels could be refractory even to high TBT doses. In mussel digestive gland the high biological variability of microsomal 7-benzyloxy-4-trifluoromethylcoumarin-O-Debenzyloxylase (BFCOD) activity, taken as a measure of CYP3A-like efficiency, probably concealed any enzyme response to TBT exposure. On the other hand the TBT-driven enhancement of BFCOD activity in vitro was once again ascribed to covalent binding to thiol groups which, in this case, would stimulate the enzyme activity. In mussels from Barcelona harbour, a highly contaminated site, the enzyme showed a decreased affinity for the 7-benzyloxy-4-trifluoromethylcoumarin (BCF) substrate with respect to mussel sampled from Ebro Delta, a non-polluted marine site. Contaminant exposure may thus alter the kinetic features of enzymes involved in detoxification mechanisms. Contaminants and steroid hormones were clearly shown to mutually interact in the modulation of detoxification mechanisms. The xenoestrogen 17α-ethylenyl estradiol (EE2) displayed a non-competitive mixed inhibition of CYP3A-like activity by a preferential bond to the free enzyme both in Barcelona harbour and Ebro Delta mussels. The possible interaction with co-present contaminants in Barcelona harbour mussels apparently lessened the formation of the ternary complex enzyme-EE2-BCF. The whole of data confirms TBT as membrane toxicant in mussels as in other species and stresses TBT covalent binding to protein thiols as a widespread mechanism of membrane-bound-enzyme activity modulation by the contaminant.

Transkriptionskontrolle des nuoA-N Operons (NADH-Dehydrogenase I) von Escherichia coli

Das Elektronentransportsystem von E. coli enthält zwei verschiedene NADH-Dehydrogenasen. Die NADH-DehydrogenaseI (nuoA-N) koppelt im Gegensatz zur NADH-DehydrogenaseII die Oxidation von NADH an eine Protonentranslokation und trägt zur Energiekonservierung bei. Die NADH-DehydrogenaseI wird über die Promotoren P1 und P2 exprimiert und besitzt mehrere Bindestellen für verschiedene Regulatoren.Die separate Klonierung der Promotoren, lacZ-Fusionen, Inaktivierung von Transkriptionsfaktoren, sowie die Nutzung mutierter Regulatorbindestellen in vivo zeigen, dass P1 im wesentlichen die Expressionshöhe bestimmt und ist unter aeroben und anaeroben Bedingungen aktiv. P2 trägt in wesentlich geringerem Maße als P1 zur Expression des Enzyms bei. Er ist stark abhängig von ArcA und IHF. Beide Promotoren wirken nicht additiv.Unter anaeroben Bedingungen wird die Transkription von nuo durch das Zweikomponenten-System ArcB/A reprimiert. ArcA bindet unabhängig und mit unterschiedlicher Affinität an die beiden Bindestellen arc1 und arc2. Von den 8 ArcA-Konsensussequenzen führen nur Mutationen der Konsensussequenzen arc1ab in vitro zu verminderter Bindungsaffinität von ArcA an die Bindestelle arc1. Dieselben führen in vivo unter anaeroben Bedingungen zur Derepression des Promotors P1 bzw. P1+P2. Unter aeroben Bedingungen zeigen nur Mutationen in arc2 eine Derepression, die nicht durch ArcA vermittelt wird. Der veröffentliche ArcA-Konsensus scheint deshalb hier in dieser einfachen Form nicht gültig zu sein.

Untersuchung der Pigment- und Proteinzusammensetzung der peripheren Lichtsammelantenne des Photosystem I

Die Lichtsammelantenne des PSI (LHCI) ist hinsichtlich ihrer Protein- und Pigmentzusammensetzung weniger gut untersucht als die des PSII. Im Rahmen dieser Arbeit wurde deshalb zunächst die Isolation von nativen LHCI-Subkomplexen optimiert und deren Pigmentzusammensetzung untersucht. Zusätzlich wurde die Pigmentbindung analysiert sowie das Pigment/Protein-Verhältnis bestimmt. Die Analyse der Proteinzusammensetzung des LHCI erfolgte mittels einer Kombination aus ein- oder zweidimensionaler Gelelektrophorese mit Westernblotanalysen mit Lhca-Protein-spezifischen Antikörpern und massenspektrometrischen Untersuchungen. Dabei stellte sich heraus, dass der LHCI mehr Proteine bzw. Proteinisoformen enthält als bisher vermutet. So gelang durch die massenspektrometrischen Untersuchungen die Identifizierung zweier bisher noch nicht nachgewiesener Lhca-Proteine. Bei diesen handelt es sich um eine Isoform des Lhca4 und ein zusätzliches Lhca-Protein, das Tomaten-Homolog des Lhca5 von Arabidopsis thaliana. Außerdem wurden in 1D-Gelen Isoformen von Lhca-Proteinen mit unterschiedlichem elektrophoretischen Verhalten beobachtet. In 2D-Gelen trat zusätzlich eine große Anzahl an Isoformen mit unterschiedlichen isoelektrischen Punkten auf. Es ist zu vermuten, dass zumindest ein Teil dieser Isoformen physiologischen Ursprungs ist, und z.B. durch differentielle Prozessierung oder posttranslationale Modifikationen verursacht wird, wenn auch die Spotvielfalt in 2D-Gelen wohl eher auf die Probenaufbereitung zurückzuführen ist. Mittels in vitro-Rekonstitution mit anschließenden biochemischen Untersuchungen und Fluoreszenzmessungen wurde nachgewiesen, dass Lhca5 ein funktioneller LHC mit spezifischen Pigmentbindungseigenschaften ist. Außerdem zeigten in vitro-Dimerisierungsexperimente eine Interaktion zwischen Lhca1 und Lhca5, wodurch dessen Zugehörigkeit zur Antenne des PSI gestützt wird. In vitro-Dimerisierungsexperimente mit Lhca2 und Lhca3 führten dagegen nicht zur Bildung von Dimeren. Dies zeigt, dass die Interaktion in potentiellen Homo- oder Heterodimeren aus Lhca2 und/oder Lhca3 schwächer ist als die zwischen Lhca1 und Lhca4 oder Lhca5. Die beobachtete Proteinheterogenität deutet daraufhin, dass die Antenne des PSI eine komplexere Zusammensetzung hat als bisher angenommen. Für die Integration „neuer“ LHC in den PSI-LHCI-Holokomplex werden zwei Modelle vorgeschlagen: geht man von einer festen Anzahl von LHCI-Monomeren aus, so kann sie durch den Austausch einzelner LHC-Monomere erreicht werden. Als zweites Szenario ist die Bindung zusätzlicher LHC vorstellbar, die entweder indirekt über bereits vorhandene LHC oder direkt über PSI-Kernuntereinheiten mit dem PSI interagieren. In Hinblick auf die Pigmentbindung der nativen LHCI-Subfraktionen konnte gezeigt werden, dass sie Pigmente in einer spezifischen Stöchiometrie und Anzahl binden, und sich vom LHCIIb vor allem durch eine verstärkte Bindung von Chlorophyll a, eine geringere Anzahl von Carotinoiden und die Bindung von ß-Carotin an Stelle von Neoxanthin unterscheiden. Der Vergleich von nativem LHCI mit rekonstituierten Lhca-Proteinen ergab, dass Lhca-Proteine Pigmente in einer spezifischen Stöchiometrie binden, und dass sie Carotinoidbindungsstellen mit flexiblen Bindungseigenschaften besitzen. Auch über die Umwandlung des an die einzelnen Lhca-Proteine gebundenen Violaxanthins (Vio) im Xanthophyllzyklus war nur wenig bekannt. Deshalb wurden mit Hilfe eines in vitro-Deepoxidationssystems sowohl native als auch rekonstituierte LHCI hinsichtlich ihrer Deepoxidationseigenschaften untersucht und der Deepoxidationsgrad von in vivo deepoxidierten Pigment-Protein-Komplexen bestimmt. Aus den Deepoxidationsexperimenten konnte abgeleitet werden, dass in den verschiedenen Lhca-Proteinen unterschiedliche Carotinoidbindungsstellen besetzt sind. Außerdem bestätigten diese Experimente, dass der Xanthophyllzyklus auch im LHCI auftritt, wobei jedoch ein niedrigerer Deepoxidationsgrad erreicht wird als bei LHCII. Dies konnte durch in vitro-Deepoxidationsversuchen auf eine geringere Deepoxidierbarkeit des von Lhca1 und Lhca2 gebundenen Vio zurückgeführt werden. Damit scheint Vio in diesen Lhca-Proteinen eher eine strukturelle Rolle zu übernehmen. Eine photoprotektive Funktion von Zeaxanthin im PSI wäre folglich auf Lhca3 und Lhca4 beschränkt. Damit enthält jede LHCI-Subfraktion ein LHC-Monomer mit langwelliger Fluoreszenz, das möglicherweise am Lichtschutz beteiligt ist. Insgesamt zeigten die Untersuchungen der Pigmentbindung, der Deepoxidierung und der Fluoreszenzeigenschaften, dass sich die verschiedenen Lhca-Proteine in einem oder mehreren dieser Parameter unterscheiden. Dies lässt vermuten, dass schon durch leichte Veränderungen in der Proteinzusammensetzung des LHCI eine Anpassung an unterschiedliche Licht-verhältnisse erreicht werden kann.

Genomische Struktur und Promotorcharakterisierung des humanen ADAM10-Gens

Das ADAM10-Gen kodiert für eine membrangebundene Disintegrin-Metalloproteinase, die das Amyloidvorläuferprotein spaltet. Im Mausmodell konnte bewiesen werden, dass die Überexpression von ADAM10 die Plaquebildung vermindern und das Langzeitgedächtnis verbessert. Aus diesem Grund ist es für einen möglichen Therapieansatz für die Alzheimer’sche Erkrankung erforderlich, die Organisation des humanen ADAM10-Gens und seines Promotors aufzuklären. Beim Vergleich der genomischen Sequenzen von humanem und murinem ADAM10 zeigte sich eine hohe Übereinstimmung. Beide Gene umfassen 160 kbp und bestehen aus 16 Exons. Die ersten 500 bp stromaufwärts vom Translationsstartpunkt zwischen dem Menschen, der Maus und der Ratte sind hoch konserviert. Diese Region beinhaltet spezifische regulatorische Elemente, die die ADAM10-Transkription modulieren. In den ersten 2179 bp stromaufwärts vom humanen ADAM10-Translationsstartpunkt fanden sich einige potentiellen Transkriptionsfaktor-bindungsstellen (Brn-2, SREBP, Oct-1, Creb1/cJun, USF, Maz, MZF-1, NFkB und CDPCR3HD). Es wurde eine charakteristische GC-Box und eine CAAT-Box, aber keine TATA-Box identifiziert. Nach Klonierung dieser 2179 bp großen Region wurde eine starke Promotoraktivität, insbesondere in neuronalen Zelllinien, gefunden. Bei der Analyse von Deletionskonstrukten wurde die Region zwischen -508 und -300 als essentiell für die Transkriptionsaktivierung bestimmt. Die Promotoraktivität wird zudem streng herunterreguliert, wenn in die Region 317 bp stromaufwärts vom Startpunkt der Translation eine Punktmutation eingeführt wird. Diese per Computeranalyse als USF-Bindungsstelle deklarierte Region spielt eine zentrale Rolle bei der ADAM10-Transkription. Im EMSA wurde eine Protein-DNA-Interaktion für diese Region gezeigt. Durch transienten Transfektionen in Schneider Drosophila Insektenzellen konnte nachgewiesen werden, dass die Überexpression von Sp1 und USp3 für die ADAM10-Promotoraktivität entscheidend ist. In EMSA-Studien bestätigte sich eine Protein-DNA-Interaktion für die Region -366 bp stromaufwärts vom Translationsstartpunkt. Die Punktmutation in der CAAT-Box veränderte die die Promotoraktivität nicht. Da weiterhin für diese potentielle Bindungsstelle kein Bindungsfaktor vorausgesagt wurde, scheint die CAAT-Box keine Bedeutung bei der Promotorregulation zu spielen. Schließlich fand sich im EMSA eine Protein-DNA-Interaktion für die Bindungsstelle 203 bp stromaufwärts vom Translationsstartpunkt. Diese in Computeranalysen als RXR-Bindungsstelle identifizierte Region ist ebenfalls von Bedeutung in der Promotorregulation. Auf der Suche nach Substanzen, die die ADAM10-Promotoraktivität beeinflussen, wurde ein negativer Effekt durch die apoptoseauslösende Substanz Camptothecin und ein positiver Effekt durch die zelldifferenzierungsauslösende Substanz all-trans Retinsäure festgestellt. Mit dieser Arbeit wurde die genomische Organisation des ADAM10-Gens zusammen mit dem zugehörigen Promotor aufgeklärt und ein neuer Regulationsmechanismus für die Hochregulation der Expression der alpha-Sekretase ADAM10 gefunden. Im Weiteren sollen nun die genauen Mechanismen bei der Hochregulation der alpha-Sekretase ADAM10 durch Retinsäure untersucht und durch Mikroarray-Analysen an RNA-Proben transgener Mäuse, welche ADAM10 überexpremieren, neue therapeutische Ansätze zur Behandlung der Alzheimer´schen Erkrankung identifiziert werden.

Systematic studies of the interaction between amyloid beta-protein and lipids

The amyloid peptide (Aß), a normal constituent of neuronal and non-neuronal cells, has been shown to be a major component of the extracellular plaque of Alzheimer’s disease (AD). The interaction of Aß peptides with the lipid matrix of neuronal cell membranes plays an important role in the pathogenesis of AD. In this study, we have developed peptide-tethered artificial lipid membranes by the Langmuir-Blodgett and Langmuir-Schaefer methods. Anti-Aß40-mAb labeled with a fluorophore was used to probe the Aß40 binding to the model membrane system. Systematic studies on the antibody or Aß-membrane interactions were carried out in our model systems by Surface Plasmon Field-Enhanced Fluorescence Spectroscopy (SPFS). Aß adsorption is critically determined by the lipid composition of the membranes. Aß specifically binds with membranes of sphingomyelin, and this preferential adsorption was markedly amplified by the addition of sterols (cholesterol or 25-OH-Chol). Fluorescence microscopy indicated that 25-OH-Chol could also form micro-domains with sphingomyelin as cholesterol does at the conditions used for the built-up of the model membranes. Our findings suggest that micro-domains composed of sphingomyelin and the sterols could be the binding sites of Aß and the role of sphingomyelin in AD should receive much more attention. The artificial membranes provide a novel platform for the study on AD, and SPFS is a potential tool for detecting Aß-membrane interaction. Numerous investigations indicate that the ability of Aß to form fibrils is considerably dependent upon the levels of ß-sheet structure adopted by Aß. Membrane-mediated conformational transition of Aß has been demonstrated. In this study, we focus on the interaction of Aß and the membranes composed of POPC/SM/25-OH-Chol (2:1:1). The artificial membrane system was established by the methods as described above. Immunoassy based on a pair of monoclonal antibodies (mAbs) against different epitopes was employed to detect the orientation of the Aß at the model membranes. Kinetics of antibody-Aß binding was determined by surface plasmon field-enhanced fluorescence spectroscopy (SPFS). The attempt has also been made to probe the change in the conformation of Aß using SPFS combined with immunoassay. Melatonin was employed to induce the conformational change of Aß. The orientation and the conformational change of Aß are evaluated by analysing kinetic/affinity parameters. This work provides novel insight into the investigation on the structure of Aß at the membrane surface.

Bioinformatische, genomweite Analyse genexpressionsregulierender Faktoren in Lebergewebe

Für eine Reihe einzelner genetischer Faktoren und Promotorelemente wurde in der Vergangenheit eine Regulation der Genexpression in der Leber (und auch in anderen Geweben) gezeigt. Mit der Verfügbarkeit des gesamten humanen Genoms sowie dessen Expressionsdaten in großen Microarray- und SAGE-Datenbanken bietet sich die Möglichkeit, solche Regulationsmechanismen in großem, genomweitem Maßstab zu untersuchen. Dabei geht diese Arbeit der Frage nach, ob es übergeordnete, eine Expression speziell in der Leber fördernde oder hemmende Faktoren gibt oder ob jedes Gen von einer unabhängigen Kombination von Faktoren reguliert wird, in dessen Summe die Expression des individuellen Gens in der Leber am stärksten ist. Sollten sich übergeordnete, eine Expression in der Leber stimulierende Faktoren finden, wären diese interessant für die Entwicklung neuer Behandlungskonzepte bei Lebererkrankungen. Zur Untersuchung dieser Fragestellung wurden aus einem Affymetrix Microarray Datenset für 12 Gewebe die Expressiondaten von insgesamt jeweils 15.472 Genen extrahiert. In einem zweiten Schritt wurden zusätzlich die Promotorsequenzen der einzelnen zugehörigen Gene, definiert als eine 1000 bp Region upstream des Transkriptionsstarts, in dieselbe Datenbank abgelegt. Die Promotorsequenzen wurden über den PromotorScan-Algorithmus analysiert. Auf diese Weise wurden Transkriptionsfaktorbindungsstellen auf 7042 der Promotoren identifiziert. Es fand sich eine Gesamtzahl von 241.984 Transkriptionsfaktorbindungsstellen. Anhand der Microarray-Expressionsdaten wurde die Gesamtgruppe der verfügbaren Gene und Promotoren in zwei Gruppen unterteilt, nämlich in die Gruppe der Gene, deren Expression in der Leber deutlich am höchsten gefunden wurde und in die Gruppe der Gene, die in anderen Geweben am höchsten exprimiert waren. Jeder potentiell bindende Transkriptionsfaktor wurde auf unterschiedliches Vorkommen in diesen beiden Gruppen hin untersucht. Dies geschah unter der Vorstellung, dass übergeordnete Faktoren, die eine Expression in der Leber stimulieren in der Gruppe der Gene, die in der Leber am höchsten exprimiert sind, verhältnismäßig wesentlich häufiger zu finden sein könnten. Eine solches häufigeres Vorkommen ließ sich jedoch für keinen einzigen Faktor nachweisen. Transkriptionsfaktorbindungsstellen sind typischerweise zwischen 5 und 15 bp lang. Um auszuschließen, dass mit dem verwendeten PromotorScan-Algorithmus Transkriptionsfaktorbindungsstellen, die bisher nicht bekannt sind, nicht übersehen wurden, wurden die Häufigkeit sämtlicher möglicher 8 bp (48) und 10 bp (410) Nukleotid-Kombinationen in diesen Promotoren untersucht. Biologisch relevante Unterschiede fanden sich zwischen den beiden Gruppen nicht. In gleicher Weise wurde auch die Bedeutung von TATA-Boxen untersucht. TATA-Boxen kommt bei der Transkriptionsinitiierung eine wichtige Rolle zu, indem über sie die Bindung des initialen Transkriptionskomplexes vermittelt wird. Insgesamt 1033 TATA-Boxen wurden ebenfalls mittels PromotorScan vorausgesagt. Dabei waren 57 auf Promotoren von Genen, die in der Leber überexprimiert waren und 976 auf Promotoren von Genen, die in anderen Geweben überexprimiert waren. Der Vergleich dieser beiden Gruppen ließ keine signifikant unterschiedliche Häufigkeit an TATA-Boxen erkennen. Im weiteren wurde die Bedeutung von CpG-Islands für eine potentiell differentielle Regulation untersucht. Insgesamt wurden 8742 CpG-Islands in einem Bereich von bis zu 5 kb upstream des Transkriptionsstarts identifiziert, 364 davon auf Promotoren von Genen, die am höchsten in der Leber exprimiert waren, 8378 auf Promotoren von Genen, die in anderen Geweben am höchsten exprimiert waren. Signifikante Unterschiede in der Verteilung von CpG-Islands auf Promotoren dieser beiden Gengruppen ließen sich nicht nachweisen. Schließlich wurden die RNA- und Proteinsequenzen des Transkriptoms und Proteoms hinsichtlich ihrer Zusammensetzung aus einzelnen Nukleotiden bzw. Aminosäuren analysiert. Auch hierbei fanden sich keine signifikanten Unterschiede in der Verteilung zwischen beiden Gengruppen. Die Zusammenschau der Ergebnisse zeigt, dass die Regulation der einzelnen Gene im Lebergewebe im wesentlichen individuell erfolgt. Im Rahmen der vorgelegten bioinformatischen Analysen fanden sich keine übergeordneten genetischen „Leberfaktoren“, die speziell eine Expression von Genen in der Leber stimulieren. Neue therapeutische Ansätze, die auf eine Regulation der Genexpression in der Leber zielen, werden somit auch weiterhin auf die Beeinflussung individueller Gene fokussiert bleiben.

Synthese, 18 F-Markierung, 11 C-Markierung und Evaluierung Hydantoin-substituierter Indolcarbonsäuren zur Visualisierung des NMDA-Rezeptorstatus mittels der Positronen-Emissions-Tomographie (PET)

Der N-methyl-D-aspartat-Rezeptor (NMDA), als Vertreter ionotroper Glutamat-Rezeptoren, ist essentiell für physiologische Lern- und Gedächtnisvorgänge und eine krankhafte Überaktivierung wird als potentielle Ursache für eine Reihe von akuten und chronischen neurodegenerativen Erkrankungen angesehen. Hierbei sind für die akuten Erkrankungen vor allem der Schlaganfall und für die chronischen Erkrankungen Morbus Parkinson sowie die Alzheimer´sche Demenz zu nennen. Durch seine einzigartige spannungsabhängige Mg2+-Blockade und der Notwendigkeit der gleichzeitigen Anwesenheit der endogenen Liganden Glutamat und Glycin zur Rezeptoraktivierung, stellt dieser Rezeptorkomplex daher ein sehr interessantes molekulares Target dar. NMDA-Rezeptor-Antagonisten der Glycin-Bindungsstelle und der verschiedenen allosterischen Bindungsstellen könnten als Neuroprotektiva bei den verschiedenen Krankheiten eine symptomatische Verbesserung bewirken und zur Therapie eingesetzt werden. Eine visuelle Darstellung des Rezeptors im Rahmen von Vorsorgeuntersuchungen ist jedoch derzeit nicht möglich. Zur Visualisierung dieser Prozesse mittels der Positronen-Emissions-Tomographie (PET) wurden basierend auf einer Hydantoin-substituierten Indol-2-carbonsäure als Leitstruktur, im Rahmen dieser Arbeit Fluorethoxy- und Methoxy-substituierte Derivate dargestellt und in pharmazeutischen und radiopharmazeutischen Studien evaluiert. Dazu wurde die Affinität und Spezifität zum Rezeptor in einem [3H]MDL-105,519 Rezeptorbindungsassay und die Lipophilie als Parameter für die Hirngängigkeit ermittelt. Anhand dieser Resultate wurden geeignete Markierungsvorläufer synthetisiert, welche eine phenolische Hydroxylfunktion besitzen und eine radioaktive Markierung mit den sekundären Markierungsvorläufern 2-[18F]Fluorethyltosylat ([18F]FETos) und [11C]Methyliodid ([11C]CH3I) ermöglichen. Unter Verwendung von 4,6-Dichlor-3-((3-(4-hydroxyphenyl)-2,4-dioxoimidazolidin-1-yl)methyl)-indol-2-carbonsäure wurde in einer Einstufenreaktion mit [18F]FETos die Zielverbindung 4,6-Dichlor-3-((3-(4-(2-[18F]fluorethoxy)phenyl)-2,4-dioxoimidazolidin-1-yl)methyl)-indol-2-carbonsäure in radiochemischen Ausbeuten von 6 % erhalten. Daher wurde eine alternative Markierung des Ethylester-geschützten Derivates 4,6-Dichlor-3-((3-(4-hydroxyphenyl)-2,4-dioxoimidazolidin-1-yl)methyl)-indol-2-carbonsäureethylester in einer Zweistufensynthese mit [18F]FETos und [11C]CH3I untersucht. Unter Verwendung dieser Strategie wurden unter optimierten Bedingungen 4,6-Dichlor-3-((3-4-(2-[18F]fluorethoxy)phenyl)-2,4-dioxoimidazolidin-1-yl)methyl)-indol-2-carbonsäureethylester und 4,6-Dichlor-3-((3-(4-[11C]methoxy-phenyl)-2,4-dioxoimidazolidin-1-yl)-methyl)-indol-2-carbonsäureethylester in radiochemischen Ausbeuten von 27 – 38 % erhalten. Die anschließende Entfernung der Schutzgruppe führte unter Bildung von Neben- und Zersetzungsreaktionen zu 4,6-Dichlor-3-((3-(4-(2-[18F]fluorethoxy)-phenyl)-2,4-dioxoimidazolidin-1-yl)methyl)-indol-2-carbonsäure und 4,6-Dichlor-3-((3-(4-[11C]methoxyphenyl)-2,4-dioxoimidazolidin-1-yl)methyl)-indol-2-carbonsäure in radiochemischen Gesamtausbeuten von 5 – 7 %. Die Überprüfung des biochemischen Konzepts in vivo durch µ-PET-Studien und durch autoradiographische Experimente an Rattenhirnschnitten, deuten auf eine niedrige in vivo-Aktivität hin, welche sich auf eine nicht ausreichende Passage der Blut-Hirn-Schranke zurückführen lässt.

Untersuchung der lateralen Organisation und Phasenumwandlung von festkörperunterstützten Lipidmembranen

Im ersten Teil der Arbeit wurde das Bindungsverhalten von Annexin A1 und Annexin A2t an festkörperunterstützte Lipidmembranen aus POPC und POPS untersucht. Für beide Proteine konnte mit Hilfe der Fluoreszenzmikroskopie gezeigt werden, dass irreversible Bindung nur in Anwesenheit von POPS auftritt. Durch rasterkraftmikroskopische Aufnahmen konnte die laterale Organisation der Annexine auf der Lipidmembran dargestellt werden. Beide Proteine lagern sich in Form lateraler Aggregate (zweidimensionale Domänen) auf der Oberfläche an, außerdem ist der Belegungsgrad und die Größe der Domänen von der Membranzusammensetzung und der Calciumkonzentration abhängig. Mit zunehmendem POPS-Gehalt und Calciumkonzentration steigt der Belegungsgrad an und der mittlere Domänenradius wird kleiner. Diese Ergebnisse konnten in Verbindung mit detaillierten Bindungsstudien des Annexins A1 mit der Quarzmikrowaage verwendet werden, um ein Bindungsmodell auf Basis einer heterogenen Oberfläche zu entwickeln. Auf einer POPC-reichen Matrix findet reversible Adsorption statt und auf POPS-reichen Domänen irreversible Adsorption. Durch die Anpassung von dynamischen Monte Carlo-Simulationen basierend auf einer zweidimensionalen zufälligen sequentiellen Adsorption konnten Erkenntnisse über die Membranstruktur und die kinetischen Ratenkonstanten in Abhängigkeit von der Calciumkonzentration und der Inkubationszeit des Proteins gewonnen werden. Die irreversible Bindung ist in allen Calciumkonzentrationsbereichen schneller als die reversible. Außerdem zeigt die irreversible Adsorption eine deutlich stärkere Abhängigkeit von der Calciumkonzentration. Ein kleinerer Belegungsgrad bei niedrigen Ca2+-Gehalten ist hauptsächlich durch die Abnahme der verfügbaren Bindungsplätze auf der Oberfläche zu erklären. Die gute Übereinstimmung der aus den Monte Carlo-Simulationen erhaltenen Domänenstrukturen mit den rasterkraftmikroskopischen Aufnahmen und die Tatsache, dass sich die simulierten Resonanzfrequenzverläufe problemlos an die experimentellen Kurven aus den QCM-Messungen anpassen ließen, zeigt die gute Anwendbarkeit des entwickelten Simulationsprogramms auf die Adsorption von Annexin A1. Die Extraktion der kinetischen Parameter aus dem zweidimensionalen RSA-Modell ist mit Sicherheit einem einfachen Langmuir-Ansatz überlegen. Bei einem Langmuir-Modell erfolgt eine integrale Erfassung einer einzelnen makroskopischen Geschwindigkeitskonstante, während durch das RSA-Modell eine differenzierte Betrachtung des reversiblen und irreversiblen Bindungsprozesses möglich ist. Zusätzlich lassen sich mikroskopische Informationen über die Oberflächenbeschaffenheit gewinnen. Im zweiten Teil der Arbeit wurde das thermotrope Phasenverhalten von festkörperunterstützten Phospholipidbilayern untersucht. Dazu wurden mikrostrukturierte, frei stehende Membranstreifen präpariert und mit Hilfe der bildgebenden Ellipsometrie untersucht. Dadurch konnten die temperaturabhängigen Verläufe der Schichtdicke und der lateralen Membranausdehnung parallel beobachtet werden. Die ermittelten Phasenübergangstemperaturen von DMPC, diC15PC und DPPC lagen 2 - 3 °C oberhalb der Literaturwerte für vesikuläre Systeme. Außerdem wurde eine deutliche Verringerung der Kooperativität der Phasenumwandlung gefunden, was auf einen großen Einfluss des Substrats bei den festkörperunterstützten Lipidmembranen schließen lässt. Zusätzlich wurde ein nicht systematischer Zusammenhang der Ergebnisse von der Oberflächenpräparation gefunden, der es unabdingbar macht, bei Untersuchungen von festkörperunterstützten Substraten einen internen Standard einzuführen. Bei der Analyse des thermotropen Phasenübergangsverhaltens von DMPC/Cholesterol - Gemischen wurde daher die individuelle Adressierbarkeit der strukturierten Lipidmembranen ausgenutzt und ein Lipidstreifen aus reinem DMPC als Standard verwendet. Auf diese Weise konnte gezeigt werden, dass das für Phospholipide typische Phasenübergangsverhalten ab 30 mol% Cholesterol in der Membran nicht mehr vorhanden ist. Dies ist auf die Bildung einer nur durch höhere Sterole induzierten fluiden Phase mit hoch geordneten Acylketten zurückzuführen. Abschließend konnte durch die Zugabe von Ethanol zu einer mikrostrukturierten DMPC-Membran die Bildung eines interdigitierten Bilayers nachgewiesen werden. Die bildgebende Ellipsometrie ist eine sehr gute Methode zur Untersuchung festkörperunterstützter Lipidmembranen, da sie über ein sehr gutes vertikales und ein ausreichendes laterales Auflösungsvermögen besitzt. Sie ist darin zwar einem Rasterkraftmikroskop noch unterlegen, besitzt dafür aber eine einfachere Handhabung beim Umgang mit Flüssigkeiten und in der Temperierung, eine schnellere Bildgebung und ist als optische Methode nicht-invasiv.